tirzepatide and chronic kidney disease Long-Term Demonstrates Benefits in Patients With CKD, Obesity, HFpEF Tirzepatide Reduces Progression of Chronic
Description
The company said the study data does not establish a "causal association" between the medications and the condition
It mimics the action of glucagon-like peptide-1, a hormone that helps regulate appetite, satiety and blood sugar response
Treatment selection and dosing are determined by a licensed clinician based on the patients intake and medical history
Due to drug shortages, the availability of brand-name obesity medications like Wegovy and Zepbound has been significantly impacted, leading patients to seek alternatives
(Data compiled from Reuters, 2024
While semaglutide can effectively suppress appetite, it does not replace the need for a balanced diet and regular physical activity
